0R15 9080.0 0.0% 0R1E 9565.0 0.0% 0M69 None None% 0R2V 237.05 13.693% 0QYR 1560.0 -0.7634% 0QYP 417.0 1.8315% 0RUK None None% 0RYA 1557.0 0.0% 0RIH 190.65 0.0% 0RIH 193.8 1.6522% 0R1O 217.5 9900.0% 0R1O None None% 0QFP 10717.21 112.6431% 0M2Z 295.8502 1.1713% 0VSO 32.02 -10.0688% 0R1I None None% 0QZI 595.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 227.3538 0.4926%

ImmuPharma PLC

Healthcare GB IMM

2.9GBP
-(-%)

Last update at 2025-01-15T18:12:00Z

Day Range

2.763.49
LowHigh

52 Week Range

1.503.80
LowHigh

Fundamentals

  • Previous Close 2.90
  • Market Cap7.15M
  • Volume10956385
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.56814M
  • Revenue TTM0.07M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.12M
  • Diluted EPS TTM-0.01

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.45633M -8.94072M -7.24618M -6.74436M -7.95516M
Minority interest - - - - -
Net income -3.80743M -8.17390M -6.85993M -6.12359M -7.20655M
Selling general administrative 0.85M 1.01M 1.76M 1.83M 1.66M
Selling and marketing expenses - - - - -
Gross profit - 0.12M 0.13M 0.08M 0.08M
Reconciled depreciation 0.12M 0.11M 0.17M 0.09M 0.13M
Ebit -3.02895M -6.58695M -5.58943M -6.28164M -8.08018M
Ebitda -2.88280M -5.04465M -5.37739M -6.12959M -7.81729M
Depreciation and amortization 0.15M 1.54M 0.21M 0.15M 0.26M
Non operating income net other - - - - -
Operating income -3.02895M -6.58695M -5.58943M -6.28164M -8.08018M
Other operating expenses 3.03M 5.28M 5.72M 6.36M 8.16M
Interest expense 1.46M 2.35M 1.70M 0.53M 0.00478M
Tax provision -0.64890M -0.76681M -0.38625M -0.62077M -0.74861M
Interest income 0.03M 0.00065M 0.04M 0.00574M 0.01M
Net interest income -1.42738M -0.20525M -1.65674M 0.00170M 0.00771M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.64890M -0.76682M -0.38625M -0.62077M -0.74861M
Total revenue 0.00000M 0.12M 0.13M 0.08M 0.08M
Total operating expenses 3.03M 5.28M 5.72M 6.36M 8.16M
Cost of revenue - - - - -
Total other income expense net -1.42738M -2.35377M -1.65674M -0.46272M 0.13M
Discontinued operations - - - - -
Net income from continuing ops -3.80743M -8.17391M -6.85993M -6.12359M -7.20655M
Net income applicable to common shares - -8.17390M -6.85993M -6.12359M -7.20655M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3.97M 6.00M 10.92M 5.80M 8.66M
Intangible assets 0.47M 0.48M 0.48M 0.48M 0.48M
Earning assets - - - - -
Other current assets - 1.75M 1.57M 2.27M 1.10M
Total liab 1.45M 1.58M 1.26M 0.53M 1.03M
Total stockholder equity 2.52M 4.41M 9.65M 5.27M 7.62M
Deferred long term liab